Figure 3
(a) Disease-free survival is improved in androgen receptor-positive triple-negative breast cancer. (b) Overall survival shows a trend for improvement in androgen receptor-expressing triple-negative breast tumors. (c) Disease-free survival in androgen receptor-positive, basal-like triple-negative breast cancer shows a trend for improvement as compared with androgen receptor-negative cases. (d) Although the difference in overall survival between androgen receptor-positive and -negative tumors in basal-like triple-negative breast carcinoma is not statistically significant, the graph displays a more favorable curve for androgen receptor-positive cases.
